International perspectives on AI-driven pharmaceutical IP challenges

Artificial Intelligence (AI) is transforming the pharmaceutical sector by optimizing care delivery and accelerating drug design. While AI introduces significant benefits, it presents complex challenges regarding intellectual property (IP) frameworks. This review examines AI-driven innovations in per...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Grace Y. Wang, Jian-Ming Hao, Joe G. Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-06-01
Colecção:	Frontiers in Digital Health
Assuntos:	artificial intelligence copyright inventorship international perspective drug discovery intellectual property
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fdgth.2026.1774406/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!